Clinical Trials Directory

Trials / Completed

CompletedNCT01720628

The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
86 (actual)
Sponsor
Turkish Ophthalmology Society · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Objectives: Behçet's disease (BD) is a systemic vasculitis. Since vascular endothelial dysfunction plays a prominent role in the pathogenesis of the disease, we considered angiogenic cytokines as an interesting target for investigation in BD. The aim of this study was to investigate the possible role of angiogenin, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in the pathogenesis of BD. Design and Methods: Sixty five patients with BD and 21 healthy control subjects were included in the study. Serum angiogenin, bFGF and VEGF concentrations were determined by using in vitro enzyme immunoassay (ELISA) kits according to the manufacturer's instructions.

Conditions

Interventions

TypeNameDescription
OTHERserum levels of angiogenin, bFGF, VEGFBehçet's patients

Timeline

Start date
2011-11-01
Primary completion
2011-11-01
Completion
2012-02-01
First posted
2012-11-02
Last updated
2012-11-02

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01720628. Inclusion in this directory is not an endorsement.

The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease (NCT01720628) · Clinical Trials Directory